Marinomed Biotech AG | WebDisclosure

Basculer en Français

10368	Companies
215969	Keywords
145712	Articles
114376	Press releases

Home
Companies
Marinomed Biotech AG

PRESS RELEASE

published on 11/12/2024 at 07:45, 1 year 5 months ago

Marinomed Biotech AG publishes clinical data for decongestant Carragelose nasal spray in peer-reviewed International Journal of General Medicine
Marinomed Biotech AG publishes clinical data for decongestant Carragelose nasal spray in peer-reviewed International Journal of General Medicine, showing significant improvement in breathing for allergic rhinitis patients

Clinical Data Marinomed Biotech AG Carragelose Nasal Spray Allergic Rhinitis
BRIEF

published on 10/11/2024 at 12:53, 1 year 6 months ago

Marinomed Biotech AG Enters Negotiations for Carragelose Portfolio Sale

Asset Deal Marinomed Biotech AG Restructuring Process Carragelose Portfolio Contract Negotiations
BRIEF

published on 10/11/2024 at 12:53, 1 year 6 months ago

Marinomed Biotech AG entame des négociations pour la vente du portefeuille de Carragelose

Marinomed Biotech AG Transaction D'actifs Portefeuille De Carragelose Négociations Contractuelles Processus De Restructuration
PRESS RELEASE

published on 10/11/2024 at 12:48, 1 year 6 months ago

EQS-Adhoc: Marinomed Biotech AG begins contract negotiations for the sale of the Carragelose portfolio
Marinomed Biotech AG initiates contract negotiations for the sale of Carragelose portfolio, aiming for long-term strategy through strategic company decision

Strategic Decision Sale Marinomed Biotech AG Carragelose Portfolio Contract Negotiations
BRIEF

published on 10/08/2024 at 07:50, 1 year 6 months ago

Marinomed Biotech AG Reports Positive Trial Results for Tacrolimus Eye Drops

Clinical Trial Bioavailability Marinosolv Tacrosolv Allergic Conjunctivitis
BRIEF

published on 10/08/2024 at 07:50, 1 year 6 months ago

Marinomed Biotech AG annonce des résultats d'essais positifs pour les gouttes ophtalmiques au tacrolimus

Essai Clinique Marinosolv Biodisponibilité Tacrosolv Conjonctivite Allergique
PRESS RELEASE

published on 10/08/2024 at 07:45, 1 year 6 months ago

Marinomed Biotech AG publishes remarkable results showing alleviation of allergic eye inflammation in patients treated with Tacrolimus eye drops in peer-reviewed journal
Marinomed Biotech AG publishes study results on Tacrolimus eye drops, showing significant alleviation of allergic eye inflammation. Potential treatment for inflammatory eye diseases

Marinomed Biotech AG Study Results Ocular Surface Tacrolimus Eye Drops Allergic Eye Inflammation
BRIEF

published on 09/24/2024 at 07:50, 1 year 7 months ago

Marinomed Biotech AG Reports Positive Clinical Results for Unique Carragelose Eye Drops

Marinomed Biotech AG Carragelose Clinical Results Eye Drops Dry Eye Syndrome
BRIEF

published on 09/24/2024 at 07:50, 1 year 7 months ago

Marinomed Biotech AG annonce des résultats cliniques positifs pour ses gouttes oculaires uniques à base de carraghénane

Marinomed Biotech AG Résultats Cliniques Carraghénose Gouttes Pour Les Yeux Syndrome De L'œil Sec
PRESS RELEASE

published on 09/24/2024 at 07:45, 1 year 7 months ago

Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops
Marinomed Biotech AG reports positive clinical results for Carragelose eye drops, improving dry eye symptoms by 54%. The eye drops are well tolerated and hold valid Medical Device Directive certificate

Marinomed Biotech AG Carragelose Clinical Results Dry Eye Eye Drops

Accesswire

Published on 05/08/2026 at 01:50, 4 hours 49 minutes ago

Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 5 hours 54 minutes ago

Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 6 hours 39 minutes ago

Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 7 hours 9 minutes ago

Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 7 hours 24 minutes ago

BULGOLD Adopts Semi-Annual Financial Reporting

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 23:23, 7 hours 15 minutes ago

H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 7 hours 25 minutes ago

EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 8 hours 34 minutes ago

Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 9 hours 57 minutes ago

RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 11 hours 53 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/07/2026 at 19:15, 11 hours 24 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 11 hours 24 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 11 hours 33 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 11 hours 33 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 11 hours 39 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE